Skip to content
PodSubs
ShowsPeopleGuestsJobsNewsEvents
More
BlogPodCred
Menu
ShowsPeopleGuestsJobsNewsEventsBlogPodCredNetworksSign in
Join nowSign in
  • Shows
  • People
  • Jobs
  • News
  • More
    • Guests
    • Events
    • Blog
    • PodCred
    • Networks
    Join nowSign in

Beginner's Mind

Beginner's Mind artwork

EP 134 - The Secret Sauce of California’s Biotech Success Revealed by Joe Panetta

Jun 22, 20241 hr 5 minAudio
ShareXLinkedInFacebookWhatsAppEmail

🚀 Discover the Secret Sauce Behind California’s Biotech Success with Joe Panetta Unlock the keys to California’s biotech boom as we delve into the insights of Joe Panetta, President and CEO of Biocom California. In this episode, we explore the unique factors that have made California a global leader in biotech innovation. Whether you’re a CEO, investor, or biotech enthusiast, this episode offers invaluable lessons and strategies. 🎙️ What's in the Episode: 1️⃣ Convergence of Science and AI: Learn how the integration of advanced technologies is revolutionizing biotech. 2️⃣ Risk-Taking Culture: Understand the cultural elements that drive California’s unparalleled biotech success. 3️⃣ Strategic Global Collaborations: Discover how international partnerships are shaping the future of biotech in California. 👨‍💼 About Joe Panetta: Joe Panetta is a pivotal figure in the biotech industry, leading Biocom California, which represents over 1,800 members. With decades of experience, Joe provides a deep dive into the strategies and innovations that have positioned California at the forefront of biotech. 💡 LINKS TO MORE CONTENT Host: Christian Soschner 📌 Quotes: (00:08:28) "We're on the verge of an era where science and AI converge for better results." (00:26:14) "California's secret sauce is its culture of risk-taking and pursuit of great rewards." (00:29:34) "An open market for pricing and selling drugs attracts biotech innovators to the U.S." (00:46:10) "Companies will seek secure alternatives for manufacturing and research, not solely depend on China." (00:57:42) Joe Panetta: "It's a shame our governor's office offers no support to the biotech industry." ⏰ Timestamps: (00:02:00) Insights from BIO 2022: Key Takeaways and Future Trends (00:08:00) Convergence in Biotech: Merging Technologies and Global Collaboration (00:15:36) Expanding Biocom's Influence: From Local to National Impact (00:21:23) Global Partnerships: California's Strategy for International Biotech Collaboration (00:26:14) California's culture of risk-taking: The secret sauce for biotech success (00:32:08) Embracing failure: The key to thriving in California's biotech ecosystem (00:42:40) California Dreamin': The Importance of a California Office for Biotech Companies (00:47:25) The Changing Face of Bio: New Technologies and Global Partnerships at the Forefront (00:55:27) Building Bridges: Governor Schwarzenegger's Biotech Legacy (00:59:38) Collaborative Catalyst: Government's Role in Biotech Advancement Send us Fan Mail Support the show Join the Podcast Newsletter: Link Your Next Move: Link

Audio and video play straight from the show's own hosting. PodSubs stores and serves no media.

Hosts and Guests

Nobody is credited on this episode yet.

Credit the people on this episode

Be the first to rate this episode

More episodes

All episodes
  1. Spark 20: Alex Dang | Everyone Agrees? Think Again. How Venture Capitalists Decide

    Nov 1, 202629 minAudio

    Invest in the wrong startup and you lose one times your money. Miss the next Google and you lose ten thousand times. Most boards are built to avoid the first mistake. Venture capitalists play by different rules. They...

    Credit the people on this episode

  2. EP 185: Ivy Nguyen | IQ, EQ and the Execution Quotient Investors Fund

    Oct 18, 20261 hr 4 minAudio

    The trait a Silicon Valley AI investor rewards most in a management team has a name almost nobody uses: XQ. IQ brings the idea and EQ reads the people across the table. The execution quotient shows in something as small...

    Credit the people on this episode

  3. EP 184: Ivy Nguyen | 10,000 AI Pitches and the One Test That Matters

    Oct 15, 202659 minAudio

    In 2017 another investor told Ivy Nguyen that artificial intelligence was too small a niche to dedicate a fund to. More than ten thousand AI pitches later, every pitch deck says AI. Single funding rounds have grown...

    Credit the people on this episode

  4. EP 183: Marie Schroeder | Send the Rough Deck, Not the Perfect One

    Sep 27, 20262 hr 5 minAudio

    A seed investor at Novo Holdings would rather read your rough idea than your finished pitch deck. Most founders spend a year building the deck, forming the team and waiting until the story holds together. By the time it...

    Credit the people on this episode

  5. #182 - How to Lead When You Don't Know Where You Are Going: 4 Lessons from Ben Horowitz (Part 2 of 2)

    Sep 8, 202657 minAudio

    What does it mean when the most respected adviser in Silicon Valley tells you that you are the best chief executive he works with, while your company is heading straight into a wall? Bill Campbell said exactly that to...

    Credit the people on this episode